Mewburn Ellis is a European intellectual property (IP) firm specialising in patents and IP strategy for artificial intelligence (AI), medical technology (MedTech) and digital health innovation.
Our attorneys help companies, investors, universities and innovators protect and commercialise breakthrough healthcare technologies through patents, freedom-to-operate, trade secrets and strategic IP advice.
We have extensive experience supporting innovation across AI-assisted diagnostics, medical imaging, clinical decision support systems, surgical robotics, wearable technologies, remote patient monitoring, digital therapeutics, bioinformatics and personalised medicine. Our multidisciplinary team combines deep expertise in AI, software and medical technologies with a practical understanding of the commercial and regulatory challenges facing healthcare innovators.
From early-stage start-ups and university spinouts to global MedTech and healthcare organisations, we help clients build, protect and maximise the value of their intellectual property in Europe and internationally.
